LIVE EHA 2026 Live from Stockholm — KOL insights, late-breaker trials & top physician voices View Live Updates →
KOL Pulse Insights Blog

Oncology KOL Intelligence, decoded.

Key opinion leader trends, clinical-trial commentary, conference recaps, and AI-native intelligence on the physicians shaping oncology practice — straight from the social conversation.

41Articles
WeeklyNew insights
500+Verified oncologists tracked
0 articles · All topics
KOL PULSE
Dec 15, 2025 6:07:43 AM Brian Shields

MajesTEC-3 Network Analysis

Majestec-3 Network analysis

Dr. Vinay Prasad's Views on Key ASCO Breast Cancer Trials
May 8, 2025 6:12:12 AM Brian Shields

Dr. Vinay Prasad's Views on Key ASCO Breast Cancer Trials

Dr. Vinay Prasad is now Director of FDA's CBER Division, Review his thoughts on NATALEE, DESTINY-Breast04, and postMONARCH breast cancer clinical trials

ASCO23asco24breast cancer
DESTINY-Breast09 is Trending, What About PATINA?
Apr 23, 2025 12:15:07 PM Brian Shields

DESTINY-Breast09 is Trending, What About PATINA?

Breast Cancer experts from the global KOL community have been buzzing about DESTINY-Breast09 and PATINA clinical trials. Track their social media insights.

sabcs24destiny-breast09breast cancer
MARIPOSA Trial Investigator Shares the Inside Scoop
Apr 22, 2025 7:55:46 AM Brian Shields

MARIPOSA Trial Investigator Shares the Inside Scoop

Blog review of a powerful video discussion by Dr. Marcelo Corassa reviewing the important clinical trials of EGFRmut NSCLC including MARIPOSA and FLAURA2

egfrmutmariposaosimertinib
How Does KOL Pulse AI Compare to the 800lb Gorillas? (Veeva Link, IQVIA, etc)
Apr 21, 2025 5:53:48 PM Brian Shields

How Does KOL Pulse AI Compare to the 800lb Gorillas? (Veeva Link, IQVIA, etc)

Discover how KOL Pulse AI challenges legacy SAAS platforms by delivering precise, real-time insights tailored for the oncology research & MSL community

AIMedical Science LiaisonVeeva
The UK Just Approved Blenrep for Myeloma, What do Top KOLs think?
Apr 21, 2025 12:28:15 PM Brian Shields

The UK Just Approved Blenrep for Myeloma, What do Top KOLs think?

Key Opinion Leaders in Multiple Myeloma express their beliefs regarding the potential return of Blenrep to the US based on DREAMM-7 and DREAMM-8

myelomaBlenrepDREAMM-7
Lung Cancer KOLs Use Memes to Communicate EGFRmut Treatments
Apr 15, 2025 6:40:12 AM Brian Shields

Lung Cancer KOLs Use Memes to Communicate EGFRmut Treatments

Lung Cancer Key Opinion Leaders, KOLs, are using memes to communicate the complicated treatment decisions for EGFRmut NSCLC based on the FLAURA2, MARIPOSA

egfrmutmariposaosimertinib
DeLLphi-304 Tweet Leaders
Apr 12, 2025 11:55:28 AM Brian Shields

DeLLphi-304 Tweet Leaders

Amgen just released a Press release on the DELLPHI-304 data, Check out what top KOLs have to say about this data set.

CheckMate 8HW YouTube Review: Oncology Brothers with Dr. Alok Khorana
Apr 12, 2025 8:56:27 AM Brian Shields

CheckMate 8HW YouTube Review: Oncology Brothers with Dr. Alok Khorana

KOL Pulse review of the Oncology Brothers podcast featuring Dr. Alok Khorana. covering the CheckMate 8HW pivotal trial fcr MSI high colorectal cancer

CheckMate 8Hwoncology brothersnivolumab
CheckMate 8HW KOL Network Visualization
Apr 10, 2025 2:37:46 PM Brian Shields

CheckMate 8HW KOL Network Visualization

AI generated network visualization of the KOL influencers of the CheckMate 8HW clinical trial discussion.

CheckMate 8HW KOL Leaderboard
Apr 10, 2025 2:30:49 PM Brian Shields

CheckMate 8HW KOL Leaderboard

KOL Pule AI Pie Chart Leaderboard of CheckMate 8HW KOL influencers by engagement

CheckMate 8HW Sentiment BCG Matrix
Apr 10, 2025 2:24:50 PM Brian Shields

CheckMate 8HW Sentiment BCG Matrix

KOL PulseAI demo of the Sentiment BCG Matrix for the CheckMate 8HW clinical trial.

CheckMate 8HW AI Sentiment Dashboard Demo
Apr 10, 2025 12:55:22 PM Brian Shields

CheckMate 8HW AI Sentiment Dashboard Demo

Producing an AI generated professional social media sentiment analysis of the CheckMate 8DW Clinical trial

DESTINY-Breast06 AI Chatbot for MSLs
Apr 6, 2025 7:10:55 AM Brian Shields

DESTINY-Breast06 AI Chatbot for MSLs

AI chatbot for DESTINY-Breast06 trial that summarizes social media insights from oncology KOLs—expert reactions, trends, and key commentary in real time

AIChatGPTDESTINY-Breast06
MARIPOSA Trial: AI Generated Global Network Visualization
Apr 4, 2025 12:40:21 PM Brian Shields

MARIPOSA Trial: AI Generated Global Network Visualization

AI Generated Network Visualization of Global Lung Cancer Leaders discussing MARIPOSA clinical trial on X. Leaders include Dr. Stephen Liu, Dr.Erik Singhi

AIlung canceregfrmut
Dr Girard Provides an Excellent Review of MARIPOSA Survival Data from #ELCC25 on YouTube
Mar 31, 2025 7:36:12 PM Brian Shields

Dr Girard Provides an Excellent Review of  MARIPOSA Survival Data from #ELCC25 on YouTube

The KOL Pulse AI tool allows a user to create a table with the leaderboard of KOL influencers and identify their key interactions and topics from #ELCC25

lung canceregfrmutmariposa
AI Generated Leaderboard: #ELCC25 Conference
Mar 31, 2025 11:15:23 AM Brian Shields

AI Generated Leaderboard: #ELCC25 Conference

The KOL Pulse AI tool allows a user to create a table with the leaderboard of KOL influencers and identify their key interactions and topics from #ELCC25

KOLAIlung cancer
NIAGARA Trial : FDA Approval Launch Pack for Clinicians
Mar 29, 2025 6:40:06 AM Brian Shields

NIAGARA Trial : FDA Approval Launch Pack for Clinicians

Key Opinion Leaders in GU Oncology have provided a plethora of resources to help clinicians process the recent FDA approval of durvalumab for MIBC based on the …

NIAGARAmibcdurvalumab
Is Ivonescimab Too Good To Be True? Highlights of Dr. John Heymach's Uromigos Podcast
Mar 26, 2025 5:34:39 PM Brian Shields

Is Ivonescimab Too Good To Be True? Highlights of Dr. John Heymach's Uromigos Podcast

Dr. John Heymach provided the Uromigos with a review on the HARMONi-2 trial of ivonescimab in NSCLC

lung cancerivonescimaburomigos
ASCO23 Flashback: Dr. Prasad's Video Criticisms of ADAURA
Mar 20, 2025 4:52:07 AM Brian Shields

ASCO23 Flashback: Dr. Prasad's Video Criticisms of ADAURA

Amid the hype of the plenary session at ASCO23, Dr. Vinay Prasad criticized the study design and ethical implementation of AstraZeneca's ADAURA trial.

asco24lung canceregfrmut
The KOL Pulse AI Advantage for Oncology Professionals
Mar 18, 2025 11:38:09 AM Brian Shields

The KOL Pulse AI Advantage for Oncology Professionals

KOL Pulse AI has many advantages for MSL organizations vs the internal IT data lake structure. Hand-curated data sets = High TRUST and AUTHORITY

KOLAIdata lake
GU Cancer Researchers Discuss Latest Breakthroughs at #GU25
Feb 27, 2025 7:10:55 AM Brian Shields

GU Cancer Researchers Discuss Latest Breakthroughs at #GU25

Leaders in GU Cancers discussed the latest breakthroughs and clinical trial updates. KOLs include Dr. Plimack, Dr. Choueiri, Dr. Powles, and Dr. Beckerman

KOL#gu25TALAPRO-2
Lung Cancer Researchers Gather at #ttlc25
Feb 25, 2025 7:41:18 AM Brian Shields

Lung Cancer Researchers Gather at #ttlc25

Lung Cancer Leaders gathered in Huntington Beach, CA to discuss Targeted Therapies in Lung Cancer at the #TTLC25 meeting.KOL Pulse AI measured the influence.

KOLlung canceregfrmut
AI Generated KOL Network Mapping - ivonescimab discussion
Feb 12, 2025 12:00:11 PM Brian Shields

AI Generated KOL Network Mapping - ivonescimab discussion

Key Opinion Leader Network Mapping through KOL Pulse AI generated social network visualization of KOL discussions of HARMONi-A from #ASCO24

asco24ivonescimabHARMONi-A
Using AI to Understand ivonescimab - KOL Pulse AI Demo
Feb 11, 2025 8:19:45 AM Brian Shields

Using AI to Understand ivonescimab - KOL Pulse AI Demo

Akeso biopharma published a preprint of the mechanism of action of ivonescimab. Can the KOL Pulse AI provide context to KOL questions about HARMONi-A?

KOLasco24Key Opinion Leader
Measuring KOL Sentiment of Oncology Clinical Trials
Jan 30, 2025 5:47:09 AM Brian Shields

Measuring KOL Sentiment of Oncology Clinical Trials

Sentiment analysis of Key Opinion Leader Tweets at Medical conferences like ASCO24 and SABCS24 has tremendous value to Pharma, physicians, and payers.

KOLKey Opinion Leadersabcs24
MARIPOSA Social Conversations Amid Promising New OS Data for Patients with EGFR-mutated NSCLC
Jan 16, 2025 2:29:01 PM Brian Shields

MARIPOSA Social Conversations Amid Promising New OS Data for Patients with EGFR-mutated NSCLC

MARIPOSA Social Network Diagram

mariposa
Not All AI is Created Equal
Dec 17, 2024 4:59:37 AM Brian Shields

Not All AI is Created Equal

Not All AI is Created Equal: Why Data Quality and Data Prompting Matter

SABCS24 Social Influence In Action
Dec 13, 2024 12:07:49 PM Brian Shields

SABCS24 Social Influence In Action

SABCS24 Social Influence Network

ASH24 Social Influencer Conversations in Full Swing
Dec 6, 2024 12:46:52 PM Brian Shields

ASH24 Social Influencer Conversations in Full Swing

ASH24 Social Influence Network

HARMONi-2 Trial: Ivonescimab vs. Pembrolizumab
Nov 6, 2024 4:05:10 PM Brian Shields

HARMONi-2 Trial: Ivonescimab vs. Pembrolizumab

On September 8th, HARMONI-2 trial data will be presented at World Lung by Akeso. In 2022, Summit, founded by Bob Duggan, bet $500M Cash and $5B Total that ivone…

WCLC24
The Wild West of World Lung Cancer #WCLC24
Sep 5, 2024 5:01:00 AM Brian Shields

The Wild West of World Lung Cancer #WCLC24

On September 8th, HARMONI-2 trial data will be presented at World Lung by Akeso. In 2022, Summit, founded by Bob Duggan, bet $500M Cash and $5B Total that ivone…

AIWCLC24
Top Lung Cancer Digital Opinion Leaders of #ASCO24
May 23, 2024 5:52:56 AM Brian Shields

Top Lung Cancer Digital Opinion Leaders of #ASCO24

Top 10 Digital Opinion Leaders in Lung Cancer in the US including Dr. Stephen Liu, Dr. Nathan Pennell, Dr. Patrick Forde, Dr. Jack West, Dr. Brendon Stiles

KOLDigital Opinion Leaderasco24
LUNAR Trial: Did Emory Get Caught in the Hype?
May 23, 2024 3:39:00 AM Brian Shields

LUNAR Trial: Did Emory Get Caught in the Hype?

Novocure's LUNAR Trial presented at ASCO23 led to a dramatic drop in the stock price of NVCR. Following ASCO23, Emory University continued to praise the LUNAR s…

LUNARTTFieldsNovocure
Prepare for Social Discussion of #ASCO24
Apr 30, 2024 5:32:20 AM Brian Shields

Prepare for Social Discussion of #ASCO24

KOL Pulse AI is a social listening tool for ASCO24. It provides Digital opinion leader and key opinion leader profiles and provides their social sentiment analy…

KOLasco24kol pulse ai
Digital KOLs of #ASH23
Dec 18, 2023 7:58:10 PM Brian Shields

Digital KOLs of #ASH23

#ASH23 digital key opinion leaders (KOLS) led the way with a collaborative online learning community to support the powerful presentations of the hematology res…

KOLHematologyASH23
Hematology KOLs Rally Behind CAR-T Cost Effectiveness Study
Dec 6, 2023 8:20:51 AM Brian Shields

Hematology KOLs Rally Behind CAR-T Cost Effectiveness Study

Hematology experts from around the world discuss the cost-effectiveness of CAR-T therapy based on new Dana-Farber Cancer Center Study

KOLASH2023CAR-T
KOL Pulse AI- The Ultimate Tool for Identifying and Analyzing Key Opinion Leaders in Healthcare
Sep 14, 2023 9:57:49 AM Brian Shields

KOL Pulse AI- The Ultimate Tool for Identifying and Analyzing Key Opinion Leaders in Healthcare

Discover how the innovative KOL Pulse app helps marketers identify healthcare key opinion leaders, and curate Twitter conversations from Medical Meetings

KOLDigital Opinion Leader
The Sci Fi Nightmare of AI and Patient Claims Data
Sep 14, 2023 9:49:38 AM Brian Shields

The Sci Fi Nightmare of AI and Patient Claims Data

Could an uncontrolled artificial intelligence application using patient claims data hack the US Healthcare System?

CRMAIScience Fiction
The Digital KOL - How Are They Different?
Sep 13, 2023 6:00:25 AM Brian Shields

The Digital KOL - How Are They Different?

Biotech, Medical Device and Pharma companies must adapt to the growing influence of Digital Opinion Leaders. Social Monitoring is a key task of MSLs.

KOLDigital Opinion LeaderMedical Science Liaison
The Digital KOLs of Interventional Neurology
Sep 13, 2023 5:12:09 AM Brian Shields

The Digital KOLs of Interventional Neurology

SNIS2023 was an impressive meeting with leaders across the neurointervention community. Which Key Opinion Leaders generate the most engagement among radiologist…

Digital Opinion LeaderSNIS2023

Track the KOLs shaping oncology

KOL Pulse turns the oncology social conversation into AI-native intelligence. See it in action.

Book a Demo Back to Homepage